Literature DB >> 16427475

Is cannabis use psychotogenic?

Wayne Hall1.   

Abstract

Mesh：

Year:  2006        PMID： 16427475     DOI： 10.1016/S0140-6736(06)68012-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Psychological and social interventions for schizophrenia.

Authors:  David Kingdon
Journal:  BMJ       Date:  2006-07-29

2.  Schizophrenia can and should be renamed.

Authors:  David G Kingdon; Yoshihiro Kinoshita; Farooq Naeem; Maged Swelam; Lars Hansen; Selveraj Vincent; Shanaya Rathod
Journal:  BMJ       Date:  2007-02-03

Review 3.  An overview of the cannabinoid type 2 receptor system and its therapeutic potential.

Authors:  Bihua Bie; Jiang Wu; Joseph F Foss; Mohamed Naguib
Journal:  Curr Opin Anaesthesiol       Date:  2018-08       Impact factor: 2.706

4.  Adolescent cannabis use increases risk for cocaine-induced paranoia.

Authors:  Rasmon Kalayasiri; Joel Gelernter; Lindsay Farrer; Roger Weiss; Kathleen Brady; Ralitza Gueorguieva; Henry R Kranzler; Robert T Malison
Journal:  Drug Alcohol Depend       Date:  2009-11-26       Impact factor: 4.492

5.  Clearing the smoke: what do we know about adolescent cannabis use and schizophrenia?

Authors:  Matthew N Hill
Journal:  J Psychiatry Neurosci       Date:  2014-03       Impact factor: 6.186

Review 6.  Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?

Authors:  Nadia Solowij; Patricia T Michie
Journal:  J Psychiatry Neurosci       Date:  2007-01       Impact factor: 6.186

7.  Do patients think cannabis causes schizophrenia? - A qualitative study on the causal beliefs of cannabis using patients with schizophrenia.

Authors:  Anna Buadze; Rudolf Stohler; Beate Schulze; Michael Schaub; Michael Liebrenz
Journal:  Harm Reduct J       Date:  2010-09-28

8.  Acceptable terminology and subgroups in schizophrenia: an exploratory study.

Authors:  David Kingdon; Anna Gibson; Yoshihiro Kinoshita; Douglas Turkington; Shanaya Rathod; Anthony Morrison
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-01-14       Impact factor: 4.328

9.  Cannabis Use and Associated Harms among Schizophrenia Patients in a Nigerian Clinical Setting: A Case-Control Study.

Authors:  Victor Lasebikan; Olaolu O Aremu
Journal:  Front Psychiatry       Date:  2016-08-03       Impact factor: 4.157

10.  Design paper: The CapOpus trial: a randomized, parallel-group, observer-blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis.

Authors:  Carsten Hjorthøj; Allan Fohlmann; Anne-Mette Larsen; Mette T R Madsen; Lone Vesterager; Christian Gluud; Mikkel C Arendt; Merete Nordentoft
Journal:  Trials       Date:  2008-07-11       Impact factor: 2.279
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.